Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan
· Delayed Price · Currency is TWD 110.00
-0.50 (-0.45%)
Mar 10, 2026, 1:30 PM CST
Syngen Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 275.47 | 341.93 | 366.89 | 246.05 | 314.8 | Upgrade
|
| Cash & Short-Term Investments | 275.47 | 341.93 | 366.89 | 246.05 | 314.8 | Upgrade
|
| Cash Growth | -19.44% | -6.80% | 49.11% | -21.84% | -25.65% | Upgrade
|
| Accounts Receivable | 462.13 | 422.56 | 387.8 | 472.06 | 388.16 | Upgrade
|
| Other Receivables | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Receivables | 462.14 | 422.56 | 387.8 | 472.06 | 388.16 | Upgrade
|
| Inventory | 361.67 | 345.62 | 348.99 | 369.35 | 291.96 | Upgrade
|
| Prepaid Expenses | 41.91 | 44.93 | 28.77 | 25.42 | 23.17 | Upgrade
|
| Total Current Assets | 1,141 | 1,155 | 1,132 | 1,113 | 1,018 | Upgrade
|
| Property, Plant & Equipment | 1,459 | 1,518 | 1,526 | 1,543 | 1,035 | Upgrade
|
| Long-Term Investments | 333.08 | 324.34 | 331.74 | 313.75 | 293.55 | Upgrade
|
| Other Intangible Assets | 37.87 | 27.57 | 24.13 | 22.96 | 23.42 | Upgrade
|
| Long-Term Deferred Tax Assets | 16.89 | 18.86 | 17.44 | 16.21 | 12.32 | Upgrade
|
| Other Long-Term Assets | 59.61 | 38.4 | 73.21 | 58.7 | 28.23 | Upgrade
|
| Total Assets | 3,048 | 3,085 | 3,106 | 3,071 | 2,416 | Upgrade
|
| Accounts Payable | 234.75 | 255.87 | 226.47 | 248.45 | 236.86 | Upgrade
|
| Accrued Expenses | - | 78.84 | 72.8 | 79.89 | 64.72 | Upgrade
|
| Short-Term Debt | - | - | 80 | 230 | - | Upgrade
|
| Current Portion of Long-Term Debt | 59.03 | 59.03 | 59.03 | - | - | Upgrade
|
| Current Portion of Leases | 15.17 | 14.71 | 13.38 | 14.85 | 13.7 | Upgrade
|
| Current Income Taxes Payable | 33.55 | 35.18 | 62.06 | 76.99 | 58.39 | Upgrade
|
| Current Unearned Revenue | 37.16 | 24.83 | 20.04 | 6.73 | 6.55 | Upgrade
|
| Other Current Liabilities | 139.93 | 51.7 | 50.81 | 62.56 | 38.4 | Upgrade
|
| Total Current Liabilities | 519.58 | 520.16 | 584.58 | 719.47 | 418.61 | Upgrade
|
| Long-Term Debt | 4.92 | 163.95 | 222.97 | 182 | 50 | Upgrade
|
| Long-Term Leases | 146.08 | 160.25 | 163.1 | 173.93 | 172.39 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.32 | 4.17 | 3.98 | 3.93 | 3.16 | Upgrade
|
| Total Liabilities | 674.89 | 848.52 | 974.63 | 1,079 | 644.16 | Upgrade
|
| Common Stock | 271.01 | 271.01 | 271.01 | 271.01 | 271.01 | Upgrade
|
| Additional Paid-In Capital | 610.94 | 618.24 | 618.2 | 618.06 | 612.83 | Upgrade
|
| Retained Earnings | 1,480 | 1,344 | 1,243 | 1,103 | 887.88 | Upgrade
|
| Comprehensive Income & Other | 10.95 | 2.73 | -0.26 | -0.07 | -0.36 | Upgrade
|
| Shareholders' Equity | 2,373 | 2,236 | 2,132 | 1,992 | 1,771 | Upgrade
|
| Total Liabilities & Equity | 3,048 | 3,085 | 3,106 | 3,071 | 2,416 | Upgrade
|
| Total Debt | 225.19 | 397.93 | 538.49 | 600.78 | 236.08 | Upgrade
|
| Net Cash (Debt) | 50.27 | -56 | -171.6 | -354.73 | 78.72 | Upgrade
|
| Net Cash Growth | - | - | - | - | -54.53% | Upgrade
|
| Net Cash Per Share | 1.85 | -2.06 | -6.33 | -13.07 | 2.90 | Upgrade
|
| Filing Date Shares Outstanding | 27.12 | 27.1 | 27.1 | 27.1 | 27.1 | Upgrade
|
| Total Common Shares Outstanding | 27.12 | 27.1 | 27.1 | 27.1 | 27.1 | Upgrade
|
| Working Capital | 621.61 | 634.89 | 547.87 | 393.41 | 599.48 | Upgrade
|
| Book Value Per Share | 87.52 | 82.51 | 78.66 | 73.49 | 65.36 | Upgrade
|
| Tangible Book Value | 2,335 | 2,209 | 2,107 | 1,969 | 1,748 | Upgrade
|
| Tangible Book Value Per Share | 86.12 | 81.49 | 77.76 | 72.64 | 64.50 | Upgrade
|
| Land | - | 251 | 251 | 251 | - | Upgrade
|
| Buildings | - | 729.7 | 717.09 | 702.28 | 532.98 | Upgrade
|
| Machinery | - | 1,022 | 871.44 | 841.51 | 693.37 | Upgrade
|
| Construction In Progress | - | 74.67 | 146.33 | 114.01 | 111.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.